221 related articles for article (PubMed ID: 30112770)
21. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
[TBL] [Abstract][Full Text] [Related]
22. Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype.
Wibom C; Mörén L; Aarhus M; Knappskog PM; Lund-Johansen M; Antti H; Bergenheim AT
J Neurooncol; 2009 Sep; 94(3):321-31. PubMed ID: 19350207
[TBL] [Abstract][Full Text] [Related]
23. Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes.
Durand A; Champier J; Jouvet A; Labrousse F; Honnorat J; Guyotat J; Fèvre-Montange M
Clin Neuropathol; 2008; 27(5):334-45. PubMed ID: 18808065
[TBL] [Abstract][Full Text] [Related]
24. Meningioma, meningeal hemangiopericytoma (angioblastic meningioma), peripheral hemangiopericytoma, and acoustic schwannoma. A comparative immunohistochemical study.
Winek RR; Scheithauer BW; Wick MR
Am J Surg Pathol; 1989 Apr; 13(4):251-61. PubMed ID: 2648875
[TBL] [Abstract][Full Text] [Related]
25. Sclerosing meningioma: immunohistochemical analysis of five cases.
Kim NR; Im SH; Chung CK; Suh YL; Choe G; Chi JG
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):126-35. PubMed ID: 15043710
[TBL] [Abstract][Full Text] [Related]
26. ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling study.
Bouvier C; Bertucci F; Métellus P; Finetti P; Maues de Paula A; Forest F; Mokhtari K; Miquel C; Birnbaum D; Vasiljevic A; Jouvet A; Coindre JM; Loundou A; Figarella-Branger D
Acta Neuropathol Commun; 2013 May; 1():10. PubMed ID: 24252471
[TBL] [Abstract][Full Text] [Related]
27. Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.
Korhonen K; Salminen T; Raitanen J; Auvinen A; Isola J; Haapasalo H
J Neurooncol; 2006 Oct; 80(1):1-7. PubMed ID: 16703453
[TBL] [Abstract][Full Text] [Related]
28. Secretory meningiomas: clinical and immunohistochemical observations.
Buhl R; Hugo HH; Mihajlovic Z; Mehdorn HM
Neurosurgery; 2001 Feb; 48(2):297-301; discussion 301-2. PubMed ID: 11220371
[TBL] [Abstract][Full Text] [Related]
29. WHO grade I meningioma subtypes: MRI features and pathological analysis.
Zhang T; Yu JM; Wang YQ; Yin DD; Fang LJ
Life Sci; 2018 Nov; 213():50-56. PubMed ID: 30153449
[TBL] [Abstract][Full Text] [Related]
30. Pseudo-continuous arterial spin labeling reflects vascular density and differentiates angiomatous meningiomas from non-angiomatous meningiomas.
Koizumi S; Sakai N; Kawaji H; Takehara Y; Yamashita S; Sakahara H; Baba S; Hiramatsu H; Sameshima T; Namba H
J Neurooncol; 2015 Feb; 121(3):549-56. PubMed ID: 25479828
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of progesterone and estrogen receptors in meningiomas.
Omulecka A; Papierz W; Nawrocka-Kunecka A; Lewy-Trenda I
Folia Neuropathol; 2006; 44(2):111-5. PubMed ID: 16823693
[TBL] [Abstract][Full Text] [Related]
32. Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas.
Chkheidze R; Cimino PJ; Hatanpaa KJ; White CL; Ferreira M; Piccirillo SGM; Li L; Rajaram S; Nyagilo JO; Burns DK; Raisanen JM; Cai C
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1081-1088. PubMed ID: 31589317
[TBL] [Abstract][Full Text] [Related]
33. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
34. Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.
Arena S; Barbieri F; Thellung S; Pirani P; Corsaro A; Villa V; Dadati P; Dorcaratto A; Lapertosa G; Ravetti JL; Spaziante R; Schettini G; Florio T
J Neurooncol; 2004 Jan; 66(1-2):155-66. PubMed ID: 15015781
[TBL] [Abstract][Full Text] [Related]
35. Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy.
Shimada S; Ishizawa K; Hirose T
Pathol Int; 2005 Jan; 55(1):1-7. PubMed ID: 15660696
[TBL] [Abstract][Full Text] [Related]
36. CD44 expression in human meningiomas: an immunohistochemical analysis.
Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
[TBL] [Abstract][Full Text] [Related]
37. Human meningiomas: immunohistochemical localization of progesterone receptor and heat shock protein 27 and absence of estrogen receptor and PS2.
Assimakopoulou M
Cancer Detect Prev; 2000; 24(2):163-8. PubMed ID: 10917137
[TBL] [Abstract][Full Text] [Related]
38. Expression of somatostatin receptors (SSTR1-SSTR5) in meningiomas and its clinicopathological significance.
Silva CB; Ongaratti BR; Trott G; Haag T; Ferreira NP; Leães CG; Pereira-Lima JF; Oliveira Mda C
Int J Clin Exp Pathol; 2015; 8(10):13185-92. PubMed ID: 26722517
[TBL] [Abstract][Full Text] [Related]
39. Somatostatin Receptor 2 Expression in Canine Meningioma.
Foiani G; Guelfi G; Chiaradia E; Mancini F; Trivelli C; Vitellozzi G; Lepri E; Mandara MT
J Comp Pathol; 2019 Jan; 166():59-68. PubMed ID: 30691608
[TBL] [Abstract][Full Text] [Related]
40. Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression.
Nagashima G; Asai J; Suzuki R; Fujimoto T
Brain Tumor Pathol; 2001; 18(1):1-5. PubMed ID: 11517968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
